Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 3,026–3,050 of 27,380 studies, newest first · page 122 of 1096.
October 2025 25
-
2025-10-01
Impact of regional white matter hyperintensity patterns on cognitive trajectories in NACC
50/100 ✓ Peer-reviewed Vascular contributions Alzheimer s & Dementia
Key finding: Compared to those with low WMH burden, participants in the mild occipital and high parieto-occipital clusters had faster memory decline; mild fronto-parietal and high parieto-occipital clusters showed faster executive decline; and mild and high fronto-parietal and high parieto-occipital clusters had faster language decline. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Effectiveness of the In-Hospital Information Technology System-Based Delirium Management Intervention Program in Medically Hospitalized Patients with Dementia: A Retrospective Case–Control Study
39/100 ✓ Peer-reviewed Clinical safety Journal of Multidisciplinary Healthcare
Key finding: The intervention group showed a significantly lower delirium incidence (34% versus 18%, p =0.010) and earlier detection of delirium after hospitalization (3.2 versus 2.2 days, p =0.035). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Prevention of cognitive impairment and dementia in people with Parkinson's disease: A call-to-action
38/100 ✓ Peer-reviewed Prevention trials Journal of Parkinson s Disease
Key finding: The main pillars of a strategic agenda for this purpose include: (i) regular assessment of cognitive state, overall risk, and risk factors for cognitive decline; (ii) risk communication and education concerning modifiable risk factors with standardized procedures; (iii) risk reduction with multi-domain interventions for secondary prevention; and (iv) cognitive enhancement with cognitive and physical training for tertiary prevention.
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC
37/100 ✓ Peer-reviewed Long-term cohort studies Alzheimer s & Dementia
Key finding: Diagnosis of LBD had high specificity but low sensitivity, with fewer than half of autopsy-confirmed cases having received an LBD diagnosis. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Evaluating cognitive impairment among a geriatric population in India using the Indian Council of Medical Research (ICMR)–multilingual dementia research and assessment (MUDRA) toolbox
46/100 ✓ Peer-reviewed Cognitive tests and assessment Indian Journal of Psychiatry
Key finding: Among 1013 participants, 847 screened positive on MoCA (70.4% mild, 13.2% moderate) for cognitive impairment and were assessed further for other domains of ICMR-MUDRA toolbox. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Impact of cerebral small vessel disease on cognitive outcomes in early age at onset MCI and dementia: Findings from the DIASPORA study
41/100 ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s & Dementia
Key finding: Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory Questionnaire (NPI-Q), and Clinical Dementia Rating (CDR) scale plus National Alzheimer's Coordinating Center-Frontotemporal Lobar Degeneration module (NACC-FTLD). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
MMSE-Based Dementia Prediction: Deep vs. Traditional Models
35/100 ✓ Peer-reviewed Cognitive tests and assessment Life
Key finding: These findings suggest that deep learning not only enhances predictive accuracy but also offers interpretable insights aligned with clinical reasoning, underscoring its potential utility as a reliable tool for early dementia diagnosis.
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Gamma sensory stimulation in mild Alzheimer's dementia: An open‐label extension study
57/100 ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s & Dementia
Key finding: No adverse events occurred over the study period. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
GLP-1 Receptor Agonists Reduce Dementia and Alzheimer Disease Risk in Patients with Diabetes and Advanced CKD: Real-World Evidence from TriNetX
47/100 ✓ Peer-reviewed Drug development Journal of the American Society of Nephrology
Key finding: GLP-1RA use was associated with lower risk of dementia (HR 0.80, 95% CI 0.71–0.91) and Alzheimer’s disease (HR 0.76, 95% CI 0.59–0.98) compared to DPP4is. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
SORL1 as a Putative Candidate Gene for a Novel Recessive Form of Complicated Hereditary Spastic Paraplegia: Insights from a Deep Functional Study
26/100 ✓ Peer-reviewed Risk genes beyond APOE Clinical and Translational Neuroscience
Key finding: Sequencing revealed a biallelic SORL1 splice donor variant (c.1211 + 1G > A). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia
38/100 ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia Translational Research & Clinical Interventions
Key finding: Compared with sMCI-resilient subjects, cMCI individuals exhibited increased frontal delta power, reduced posterior alpha power, and an elevated delta/alpha ratio in the right temporal region, consistent with cortical dysfunction. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study
48/100 ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia Translational Research & Clinical Interventions
Key finding: Cox regression analysis revealed that polypharmacy was significantly associated with a reduced risk of MCI progression to dementia (hazard ratio [HR] = 0.49, 95% confidence interval [CI]: 0.31 to 0.78) after adjusting for covariates. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years
37/100 ✓ Peer-reviewed Lewy body dementia npj Dementia
Key finding: We observed adults aged 50 years and older from the UK Biobank over a median observational period exceeding two years following COVID-19 infection. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
A review of studies on vascular dementia and iron metabolism
32/100 ✓ Peer-reviewed Lewy body dementia Science Progress
Key finding: Vascular dementia (VaD) is recognized as the second most prevalent form of dementia after Alzheimer's disease, with its pathogenesis intricately associated with cerebrovascular pathologies, including chronic hypoperfusion, oxidative stress, and neuroinflammation. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Plasma p‐tau217 and Aβ42/40 as markers of Aβ pathology in the Lewy body continuum
43/100 ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia
Key finding: Higher plasma p-tau217, lower Aβ42/40, and their interaction were associated with greater Aβ-PET uptake. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
White matter hyperintensities precede other biomarkers in GRN frontotemporal dementia
48/100 ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia
Key finding: Symptomatic GRN carriers showed elevated WMHs, primarily in the frontal lobe, while no significant increase was observed in symptomatic C9orf72 or MAPT carriers. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Risk Factors for Dementia in a Sample of Patients From a Quaternary Care Hospital Network in the United Arab Emirates
49/100 ✓ Peer-reviewed Risk factors Alzheimer Disease & Associated Disorders
Key finding: A total of 281 dementia patients (mean age 74.9 ± 9.2 y, 46.3% females) and 281 age-matched controls (mean age 74.3 ± 4.6 y, 55.9% females) were included. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Factors associated with: problems of using exploratory multivariable regression to identify causal risk factors
41/100 ✓ Peer-reviewed Risk factors BMJ Medicine
Key finding: Where mutually adjusted regression coefficients are significant, the exposures are labelled as risk factors for the outcome. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Cardiovascular risk factors and the allostatic interoceptive network in dementia
51/100 ✓ Peer-reviewed Risk factors Cardiovascular Research
Key finding: We recruited 1501 participants (304 with FTLD, 512 with AD, and 685 healthy controls) from the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Explainable and externally validated machine learning for neurocognitive diagnosis via ECGs
37/100 ✓ Peer-reviewed Digital health tools General Psychiatry
Key finding: Significant predictive performance was observed for several neurocognitive disorders. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Acceptability and feasibility of a sensor-instrumented ‘SmartSocks’ wearable prototype to detect agitation in people with dementia
35/100 ✓ Peer-reviewed Digital health tools International Psychogeriatrics
Key finding:
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Classification of AD and bvFTD using neuropsychological and neuropsychiatric variables: a machine learning study
46/100 ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia
Key finding: Among 1616 participants (AD = 1498, bvFTD = 118), all algorithms achieved high accuracy (80% to 90%) and discriminatory ability (AUC = 0.89 to 0.95). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Combined with multimodal medical imaging and artificial intelligence for early diagnosis of Parkinson's disease
40/100 ✓ Peer-reviewed Digital health tools Frontiers in Neurology
Key finding: Epidemiological data show that both PD incidence rate and prevalence rate show a significant age-dependent growth trend [3]. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Advancing early and equitable detection of dementia: key learnings/challenges, recent innovations, and future directions
42/100 ✓ Peer-reviewed Disparities The Gerontologist
Key finding: Systemic under-detection and its contributions to persistent population-level suffering underscore the importance of early detection of dementia as a key public health issue. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-10-01
Population intervention models of racial ethnic disparities in cognitive outcomes from cardiometabolic risk factors – HABS-HD
44/100 ✓ Peer-reviewed Disparities Alzheimer s Research & Therapy
Key finding: NHB Hispanic, and NHW participants prevalences were APOE ε4 (32.2%, 27.4%, 17.6%), diabetes (26.1%, 35.0%, 13.9%), hypertension (79.0%, 63.6%, 58.2%), obesity (56.8%, 50.3%, 38.5%), and tobacco dependence (12.9%, 7.5%, 3.9%). +4 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →